ArticleInternational journal of general medicine2025
Fear of Disease Progression in Patients with Type 2 Diabetes Construction and Validation of a Nomogram Prediction Model.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prevalence and associated factors of fear of progression in patients with heart failure in China: a scoping review.Frontiers in psychiatry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to understand the current situation of phobia regarding disease progression in patients with type 2 diabetes mellitus (T2DM) and identify its influencing factors. Methods: A convenient sampling method was used to select patients with T2DM who were hospitalized in a tertiary A hospital in Binzhou City, Shandong Province, from September 2024 to February 2025 as the research objects. The evaluation tools included a general information questionnaire, a simple disease perception questionnaire, a chronic disease health literacy scale, a diabetes self-management behavior scale, a family resilience scale, and a simplified scale for fear of disease progression. Factors influencing the fear of disease progression in patients with T2DM were analyzed through single-factor and binary logistic regression analyses. Results: Among 346 patients with T2DM, 124 patients exhibited fear of disease progression, with an incidence of 35.80%. Multifactor logistic regression analysis indicated that gender, place of residence, number of complications, scores on the Brief Illness Perception Questionnaire, and Family Resilience Assessment Scale were independent risk factors for fear of disease progression. Using these risk factors, a nomogram prediction model was constructed that achieved an area under the receiver operating characteristic curve of 0.814 (0.767-0.862), with a sensitivity and specificity of 76.6%. The maximum Youden index and the optimal cutoff value were determined to be 0.532 and 0.361, respectively. Internal validation results using the Bootstrap self-sampling method indicated that the calibration curve of the nomogram closely approximated the ideal curve. Conclusion: The incidence of fear of disease progression (FOP) is higher in patients with T2DM. The constructed risk prediction model has good predictive performance and can provide a reference for assessing the risk of FOP in patients with T2DM. Simultaneously, it is conducive to the formulation of intervention strategies targeting risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.